Therapeutic Monoclonal Antibodies and Antibody Products: Current Practices and Development in Multiple Myeloma

Immunotherapy is the latest innovation for the treatment of multiple myeloma (MM). Monoclonal antibodies (mAbs) entered the clinical practice and are under evaluation in clinical trials. MAbs can target highly selective and specific antigens on the cell surface of MM cells causing cell death (CD38 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonello, Francesca, Mina, Roberto, Boccadoro, Mario, Gay, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017131/
https://www.ncbi.nlm.nih.gov/pubmed/31861548
http://dx.doi.org/10.3390/cancers12010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017131/
https://www.ncbi.nlm.nih.gov/pubmed/31861548
http://dx.doi.org/10.3390/cancers12010015

Ejemplares similares